Inventor · disambiguated record
Ralf Kronenwett
Also filed as: KRONENWETT RALF
7 granted patents·10 pending applications·2 citations·filing 2008–2024
74Inventor score
Files withMYRIAD INT GMBH6MYRIAD GENETICS INC3SIVIDON DIAGNOSTICS GMBH3WIRTZ RALPH MARKUS2DARTMANN MAREIKE1
Top patents by PatentIndex Score
17 records- 0186US11505832B2Method of using biomarkers and clinical variables for predicting chemotherapy benefitMYRIAD GENETICS INC·Filed 2020·Granted Nov 22, 2022·2 cites·20 claims
- 0280US2024229150A1Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2024·Application pending·0 cites
- 0372US12180551B2Method of using biomarkers and clinical variables for predicting chemotherapy benefitMYRIAD GENETICS INC·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 0469US11913078B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2020·Granted Feb 27, 2024·0 cites·19 claims
- 0568US2022307090A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2022·Application pending·0 cites
- 0665US10851427B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2020·Granted Dec 1, 2020·0 cites·41 claims
- 0763US2019144949A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2019·Application pending·0 cites
- 0861US9932639B2Method for predicting therapy responsiveness in basal like tumorsWIRTZ RALPH MARKUS·Filed 2008·Granted Apr 3, 2018·0 cites·4 claims
- 0960US10577661B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2016·Granted Mar 3, 2020·0 cites·19 claims
- 1058US2014228241A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrentbreast cancerGEHRMANN MATHIAS·Filed 2012·Application pending·0 cites
- 1157US2013065786A1Method for breast cancer recurrence prediction under endocrine treatmentDARTMANN MAREIKE·Filed 2011·Application pending·0 cites
- 1257US2011166838A1Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancerSividon Diagnostics·Filed 2009·Application pending·0 cites
- 1352US2017081728A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2016·Application pending·0 cites
- 1452US2018251854A1Method For Predicting Therapy Responsiveness In Basal Like TumorsWIRTZ RALPH MARKUS·Filed 2018·Application pending·0 cites
- 1548US10301685B2Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2017·Granted May 28, 2019·0 cites·10 claims
- 1647US2015376714A1Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2014·Application pending·0 cites
- 1730US2016348183A1Method for predicting the response and survival from chemotherapy in patients with breast cancerMYRIAD GENETICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ralf Kronenwett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →